Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 594

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 594
---
ows from a decrease in prepaid expenses of $3.6 million, primarily related to prepaid clinical costs, partially offset by a cash outflow of $1.3 million relating to operating lease liabilities associated with Cara’s existing lease agreements for Cara’s operating facility in Stamford, Connecticut, a cash outflow of $1.2 million for an increase in other receivables, primarily due to the regulatory milestone payment earned from Maruishi in September 2023, and an $0.9 million cash outflow for an increase in inventory. Net cash provided by investing activities Net cash provided by investing activities was $43.7 million for the nine months ended September 30, 2024, which primarily included cash inflows of $77.0 million from maturities of available-for-sale marketable securities, partially offset by cash outflows of $32.3 million for the purchases of available-for-sale marketable securities and $1.0 million for the purchases of property and equipment. Net cash provided by investing activities was $73.7 million for the nine months ended September 30, 2023, which primarily included cash inflows of $122.6 million from maturities and redemptions of available-for-sale marketable securities, partially offset by cash outflows of $48.6 million for the purchases of available-for-sale marketable securities. Net cash (used in) provided by financing activities Net cash used in financing activities for the nine months ended September 30, 2024 consisted of payments made to HCR under the royalty purchase and sale agreement of approximately $2.0 million. Net cash provided by financing activities for the nine months ended September 30, 2023 consisted of proceeds of $1.1 million from the sales of common stock under Cara’s open market sales agreement and proceeds of $0.6 million received from the exercise of stock options. For the Years Ended December 31, 2023 and 2022 The following is a summary of the net cash flows provided by (used in) Cara’s operating, investing and financing activities for the years ended December 31, 2023 and 2022:

| ​                                                                     
 ​                                                                     | ​ 
 ​ | ​ 
 ​ | Year Ended December 31,     
 2023                        |   |         |   | ​ | ​ | 2022 |   |         |   | ​ 
 ​ |
|:----------------------------------------------------------------------|:--|:--|:----------------------------|:--|--------:|:--|:--